Form 4: Rockwell Medical CCO Sells Shares Under 10b5-1 Plan

Rockwell Medical's SVP and CCO, Timothy Chole, sold 2,868 shares of common stock at $1.19 per share pursuant to a pre-arranged 10b5-1 trading plan.

Summary

• Timothy Chole, the Senior Vice President and Chief Commercial Officer (SVP and CCO) of Rockwell Medical, Inc. (RMTI), reported a transaction involving the company's common stock.
• The transaction, which occurred on October 1, 2025, was a disposition (sale) of 2,868 shares of common stock.
• The shares were sold at a price of $1.19 per share.
• This sale was executed under a Rule 10b5-1 trading plan that Mr. Chole adopted on June 7, 2024.
• Following this reported transaction, Mr. Chole directly beneficially owns 125,299 shares of Rockwell Medical common stock.

Sentiment

Score: 5

Explanation: The sale of shares by a senior officer is generally viewed neutrally to slightly negatively, but the execution under a pre-arranged Rule 10b5-1 trading plan mitigates concerns about discretionary timing based on new material non-public information.

Negatives

• An insider, the SVP and CCO, sold 2,868 shares of company common stock, which can sometimes be perceived negatively by the market, though this is mitigated by the 10b5-1 plan.

Future Outlook

N/A

Industry Context

N/A

Stakeholder Impact

• Shareholders may view the sale by a senior officer as a slight negative signal, though the pre-arranged 10b5-1 plan mitigates concerns about discretionary timing.

Key Dates

Recommendation

This Form 4 reports a routine insider sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are generally not indicative of new material information and therefore do not warrant a change in investment recommendation based solely on this filing. Investors should consider broader company fundamentals and market conditions.

Keywords

Rockwell Medical, RMTI, Timothy Chole, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, SVP, CCO, Common Stock